With respect to circulating tumor cells in patients with advanced NSCLC Nicolazzo et al. found that 95% of patients had a subpopulation of PD-L1 positive of PD-L1 positive [31] similar to our results of 82% in NSCLC patients. This evidence concerns the gene CD274 and non-small cell lung carcinoma.